These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32545609)

  • 21. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial Intelligence Diagnosis of Parkinson's Disease From MRI Scans.
    Reddy S; Giri D; Patel R
    Cureus; 2024 Apr; 16(4):e58841. PubMed ID: 38784299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.
    Prasad S; Stezin A; Lenka A; George L; Saini J; Yadav R; Pal PK
    Eur J Neurol; 2018 Apr; 25(4):680-686. PubMed ID: 29341412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson's disease.
    Solana-Lavalle G; Rosas-Romero R
    Comput Methods Programs Biomed; 2021 Jan; 198():105793. PubMed ID: 33099263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's Disease Recognition Using Decorrelated Convolutional Neural Networks: Addressing Imbalance and Scanner Bias in rs-fMRI Data.
    Patil P; Ford WR
    Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics for Parkinson's disease classification using advanced texture-based biomarkers.
    Gore S; Dhole A; Kumbhar S; Jagtap J
    MethodsX; 2023 Dec; 11():102359. PubMed ID: 37791007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson's Disease From Clinical and Genetic Data.
    Faouzi J; Bekadar S; Artaud F; Elbaz A; Mangone G; Colliot O; Corvol JC
    IEEE Open J Eng Med Biol; 2022; 3():96-107. PubMed ID: 35813487
    [No Abstract]   [Full Text] [Related]  

  • 32. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values.
    Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL
    Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study.
    Kiryu S; Yasaka K; Akai H; Nakata Y; Sugomori Y; Hara S; Seo M; Abe O; Ohtomo K
    Eur Radiol; 2019 Dec; 29(12):6891-6899. PubMed ID: 31264017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting motor outcome in preterm infants from very early brain diffusion MRI using a deep learning convolutional neural network (CNN) model.
    Saha S; Pagnozzi A; Bourgeat P; George JM; Bradford D; Colditz PB; Boyd RN; Rose SE; Fripp J; Pannek K
    Neuroimage; 2020 Jul; 215():116807. PubMed ID: 32278897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep learning based diagnosis of Parkinson's Disease using diffusion magnetic resonance imaging.
    Zhao H; Tsai CC; Zhou M; Liu Y; Chen YL; Huang F; Lin YC; Wang JJ
    Brain Imaging Behav; 2022 Aug; 16(4):1749-1760. PubMed ID: 35285004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep learning enables automatic detection and segmentation of brain metastases on multisequence MRI.
    Grøvik E; Yi D; Iv M; Tong E; Rubin D; Zaharchuk G
    J Magn Reson Imaging; 2020 Jan; 51(1):175-182. PubMed ID: 31050074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term cognitive decline prediction based on multi-modal data using Multimodal3DSiameseNet: transfer learning from Alzheimer's disease to Parkinson's disease.
    Ostertag C; Visani M; Urruty T; Beurton-Aimar M
    Int J Comput Assist Radiol Surg; 2023 May; 18(5):809-818. PubMed ID: 36964477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.